As of Dec 02
| +0.10 / +7.14%|
The 1 analysts offering 12-month price forecasts for Inspyr Therapeutics Inc have a median target of 60.00, with a high estimate of 60.00 and a low estimate of 60.00. The median estimate represents a +3,900.00% increase from the last price of 1.50.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.